Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.062 0.05
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.056 0.05
mRNA foretinib GDSC1000 pan-cancer AAC -0.061 0.05
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.14 0.06
mRNA Nilotinib CCLE pan-cancer AAC -0.097 0.06
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.063 0.06
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.073 0.06
mRNA AMG-706 FIMM pan-cancer AAC 0.3 0.06
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.14 0.06
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.063 0.07
Download CSV